J44 J45 J46 I27.0 J84.1 J12 J13 J14 J15 J16 J17 J18
Conditions
Interventions
Group 1: Intervention Group - Vulnerable patients will be assigned to a patient room with radiant cooling
Group 2: Control Group - Vulnerable patients will be distributed to a patient room without rad
Sponsors
Charité Universitätsmedizin Berlin, Med. Klinik m. S Infektiologie und Pneumologie, Arbeitsbereich Ambulante Pneumologie
Eligibility
Sex/Gender
All
Age
30 Years to No maximum
Inclusion criteria
Inclusion criteria: • COPD • Asthma • Pneumonia • Lung fibrosis • Pulmonary hypertension
Exclusion criteria
Exclusion criteria: • Malignant disease (life expectancy 70mmHg, coma, hypoxemia <50mmHg, acidosis pH <7,35, circulatory insufficiency) • Instable coronary disease • Liver disease (Child-Pugh class C) • Kidney disease (glomerular filtration rate =29 mL/min/1.73m²) • Patient awaits lung transplantation • Missing or withdrawn consent • Inability to fulfil the testing and examination procedures • Room change before discharge
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total length of hospital stay (days) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Score COPD Assessment Test (CAT) 2. Score Modified British Medical Research Council Questionnaire for Dyspnoea (mMRC) 3. Body weight 4. Body temperature 5. Oxygen saturation 6. Heart rate 7. Blood pressure 8. Fluid intake 9. Step count (measurement of daily activity) | — |
Countries
Germany
Contacts
Public ContactChistian Witt
Charité Universitätsmedizin Berlin, Med. Klinik m. S Infektiologie und Pneumologie, Arbeitsbereich Ambulante Pneumologie
Outcome results
None listed